U.S FDA Clears EndyMed’s Hair Removal Device

October 20, 2022

Pure Laser is the Company's first laser-based device to receive FDA approval for marketing and sales within the US. 

The US Food and Drug Administration has cleared Endymed Ltd’s Pure Laser hair removal device for the marketing and sales.

The Pure Laser was developed in the Company's labs by its subsidiary Endymed Medical Ltd.  The Company intends to commence marketing in the US through its subsidiary, Endymed Medical Inc. and its marketing and sales team. Furthermore, the Company is working on registration and marketing of the device in other strategic countries, as well as establishing distribution agreements. 

Pure Laser is the Company's first laser-based device to receive FDA approval for marketing and sales within the US. 

Facebook Comments

Register

We’re glad to see you’re enjoying PracticalDermatology…
but how about a more personalized experience?

Register for free